A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer by Planchard, David, Wolf, Jürgen, Solomon, Benjamin, Sebastian, Martin, Wermke, Martin, Heist, Rebecca S., Sun, Jong-Mu, Min Kim, Tae, Reguart, Noemi, Sanmamed, Miguel F., Felip, Enriqueta, Garrido, Pilar, Santoro, Armando, Bootle, Douglas, Couillebault, Xuân-Mai, Gaur, Anil, Mueller, Christina, Poggio, Teresa, Yang, Jie, Moschetta, Michele, Dooms, Christophe

Get full text

A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer by Kuemmel, Sherko, Campone, Mario, Loirat, Delphine, Lopez, Rafael Lopez, Beck, J Thaddeus, De Laurentiis, Michelino, Im, Seock-Ah, Kim, Sung-Bae, Kwong, Ava, Steger, Guenther G, Adelantado, Esther Zamora, Duhoux, Francois P, Greil, Richard, Kuter, Irene, Lu, Yen-Shen, Tibau, Ariadna, Özgüroğlu, Mustafa, Scholz, Christian W, Singer, Christian F, Vega, Estela, Wimberger, Pauline, Zamagni, Claudio, Couillebault, Xuan-Mai, Fan, Liqiong, Guerreiro, Nelson, Mataraza, Jennifer, Sand-Dejmek, Janna, Chan, Arlene

Get full text

Abstract CT197: Phase Ib study of LXH254 + trametinib (TMT) in patients (pts) with NRAS -mutant melanoma by de Braud, Filippo, Dooms, Christophe, Heist, Rebecca S., Lebbe, Celeste, Wermke, Martin, Planchard, David, Schadendorf, Dirk, Rutkowski, Piotr, Wolf, Jürgen, Ascierto, Paolo A., Gil-Bazo, Ignacio, Kato, Shumei, Wolodarski, Maria, McKean, Meredith, Couselo, Eva Muñoz, Sebastian, Martin, Santoro, Armando, Cooke, Vesselina, Manganelli, Luca, Wan, Kitty, Gaur, Anil, Samant, Tanay S., Kim, Jaeyeon, Caponigro, Giordano, Couillebault, Xuân-Mai, Moschetta, Michele, Daud, Adil

Get full text